Part II: Methods and Approaches 1: Assessing Disease Associations and Interactions Chapter 10 Tables

Print

Pages in this Report

  1. Index
  2. Preface
  3. Chapter 1
  4. Chapter 4
  5. Chapter 7
  6. Chapter 9
  7. Chapter 10
  8. Chapter 11
  9. Chapter 22
  10. Chapter 23
  11. Chapter 24
  12. Chapter 28
  13. Chapter 29
Related Pages

Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease

 

Reporting and Review of Human Genome Epidemiology Studies

Julian Little

Table 10-1
Proposed checklist for reporting and appraising studies of (i) genotype prevalence, (ii) gene-disease associations, and (iii) gene-environment interactions
Genotype prevalence Gene-disease associations Genotype- environment interaction
1. Purpose of study
√
Detect associations or estimate magnitude of association
Describe joint effects; test specific hypotheses about interaction
2. Analytical validity of genotyping
Types of samples used
√
For cases and for controls
For cases and for controls
Timing of sample collection and analysis, by study group*
e.g.
ethnic group
e.g. cases vs. controls
e.g. cases vs. controls
Success rate in extracting DNA, by study group*
e.g. ethnic group
e.g. cases vs. controls
e.g. cases vs. controls
Definition of the genotype(s) investigated; when there are multiple alleles, those tested for should be specified
√
√
√
Genotyping method used (reference; for PCR methods – primer sequences*, thermocyle profile*, number of cycles*)
√
√
√
Percentage of potentially eligible subjects for whom valid genotypic data were obtained, by study group
e.g.
ethnic group
e.g. cases vs. controls
e.g. cases vs. controls
If pooling was used, strategy for pooling of specimens from cases and controls
√
Quality control measures*
√
Including blinding of laboratory staff
Including blinding of laboratory staff
Samples from each group of subjects compared (e.g cases and controls)included in each batch analyzed*
√
3. Assessment of exposures
Reproducibility and validity of exposure documented
√
Categories or exposure scale justified
√
4. Selection of study subjects
Geographical area from which subjects were recruited
√
√
√
The recruitment period
√
√
√
Recruitment methods for subjects whose genotypes were determined, such as random population-based sampling, blood donors, hospitalized subjects with reasons for hospitalization
√
Definition of cases and method of ascertainment
√
√
Number of cases recruited from families and methods used to account for related subjects
√
√
Recruitment rates
 Where possible by sex, age and ethnic group For cases and controls For cases and controls
Mean age (±SD) or age-range of study subjects, and the distribution by sex
√
 For cases and controls For cases and controls
If the subject were controls from a case-control study, information of the disease under investigation and any matching criteria such as age, gender, and/or risk factor levels
√
Ethnic group of study subjects
√
Similarity of socio-demographic (or other) characteristics of subjects for whom valid genotypic data were obtained with characteristics of subjects for whom such data were not obtained*
√
√
Steps taken to ensure that controls are non-cases*
√
5. Confounding, including population stratification
Design
√
√
If other than a case-family control design, matching for ethnicity, or adjustment for ethnicity in analysis
√
√
6. Statistical issues
Distinguish clearly a priori hypotheses and hypotheses generated
√
√
If haplotypes used, specify how these were constructed
√
√
v
Number of subjects included in the analysis, by cell numbers where possible
√
√
√
Method of analysis, with reference, and software used to do this
√
√
Confidence intervals
 Of genotype frequency Of measures of association with the genotype
For interaction analysis, 2xK presentation nused, or choice of stratified analysis justified
√
For interaction analysis, P value for interaction calculated and choice of Wald test or likelihood ratio test specified and justified
√
For interaction analysis, null interactions listed
√
Assessment of goodness-of-fit of the model used*
√
√

*Additional information recorded (ideally in web-based methods register)
[back to chapter]

 

Box 10-1
Guidelines for causal inference (modified from Hill [120] and Surgeon General [119])
  • Consistency
  • Strength
  • Dose-responsea
  • Biologic plausibility (including analogyb)a
  • Temporality
  • Experimental supporta
  • Coherence

aAdditional considerations specified by Hill (120)
bAnalogy is a variant of biologic plausibility (29, 121)

[back to chapter]